Author

Ketki Rani

Institution: Shree Guru Gobind Singh Tricentenary University

Observed institutions: Shree Guru Gobind Singh Tricentenary University, Noida Institute of Engineering and Technology Pharmacy Institute

ORCID: 0000-0002-2964-7380

Observed ORCID: 0000-0002-2964-7380

OpenAlex ID: A5024617197

Emerging Therapeutic Potential of Cannabidiol (CBD) in Neurological Disorders: A Comprehensive Review

2023 · Kuldeep Singh, Bharat Bhushan, et al. · Behavioural Neurology · 64

Advances in Molecular Docking Techniques for Targeting Protein Misfolding in Neurodegenerative Diseases

2025 · Kuldeep Singh, Jeetendra Kumar Gupta, et al. · Current Pharmaceutical Biotechnology · 6

In Silico ADMET Studies, Molecular Docking and Molecular Dynamics Simulation of Thiadiazole Derivatives for the Identification of Putative HsaA Monooxygenase Inhibitors

2025 · Min Zheng, Ankush Kumar, et al. · Current Medicinal Chemistry · 3

Harnessing Computational Modeling for Efficient Drug Design Strategies

2024 · Kuldeep Singh, Bharat Bhushan, et al. · Letters in Organic Chemistry · 2

Docking Studies of Potent Xanthine Oxidase Inhibitors-Molecules Patented and Published from 2011-2020

2022 · Tripti Arora, Ketki Rani · Oriental Journal Of Chemistry · 2

Unlocking Therapeutic Potential: Molecular Docking Insights into Aurora Kinase A Inhibitors Patented and Published from 2011-2020 for Innovative Anticancer Drug Design

2024 · Ketki Rani, Avijit Mazumder, et al. · Letters in Drug Design & Discovery · 1

Synthesis, Molecular Docking, and Biological Evaluation of Novel Indole-triazole Conjugates

2024 · Paras Berwal, Suman Rohilla, et al. · Current Drug Discovery Technologies · 1

Validated Reverse Phase High Performance Liquid Chromatography Approach via Experimental Design for Accurate Embelin Estimation in Pharmaceutical Products

2026 · Monika Dhaka, Habban Akhter, et al. · International Journal of Drug Delivery Technology

Identification of N ‐(2‐(1H‐indol‐3‐yl) ethyl)‐ N ‐benzylacrylamide as Novel Aurora Kinase A Inhibitor for Cancer Therapy: Virtual Screening, Synthesis, MD Simulation, and In Vitro Validation

2025 · Ketki Rani, Avijit Mazumder, et al. · ChemistrySelect

Works count: 9

Citation count: 78

H-index: 2

I10-index: 1